Brucellosis in the United States - Current Perspectives
= Continuing Education Credits
Date: Thursday, August 25, 2011
Time: 3:00 - 4:00 pm (Eastern Time)
Marta A. Guerra, DVM, PhD, MPH
CAPT, U.S. Public Health Service
Bacterial Special Pathogens Branch
National Center for Emerging and Zoonotic Infectious Diseases - CDC
Brucellosis is one of the most common zoonoses in the world. However, in the United States, due to eradication efforts in the veterinary and human public health sectors, the populations at risk have changed.Diagnosis and treatment of brucellosis is challenging because of nonspecific symptoms, limited availability of validated tests, and variety of antimicrobials regimens and duration of therapy.>Join us for this COCA call where a subject matter expert will review the current status of brucellosis, available diagnostics, and treatment regimens.
At the conclusion of the session, the participant will be able to accomplish the following:
- Describe populations at risk for brucellosis in the United States
- List brucellosis diagnostic methods available in the United States and advantages and disadvantages of each
- Discuss main causes of Brucella laboratory exposures and risk assessment
- Discuss treatment regimen for brucellosis and patient follow up
Slides: View Now
Webcast: Watch Now
Audio: Listen Now
Transcript: Read Now
- CDC Frequently Asked Questions About Brucellosis
- CDC Brucellosis Laboratory Information
- EID Jornal - Laboratory Exposure to Brucellae & Implications for Bioterrorism
Emerging Infectious Diseases 2005 Aug;11(8):1180-1185
Minimum system requirements
||ACTIVITY NUMBER||EC/PD/WD 1648|
|MATERIALS||PowerPoint Slide Set|
Physicians, Nurses, Pharmacist, Veterinarians, Physician Assistants and Other Clinicians
Live webcasts and audio conference call on 8/25/11: 3:00 - 4:00 PM
Web-on-demand training after 4:00 PM on 8/25/11
Centers for Disease Control and Prevention, Emergency Risk Communication Branch
|METHOD OF PARTICIPATION||
Attend the live conference call or download the materials afterwards
There is no charge for COCA continuing education credits
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this electronic conference/web-on-demand educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Non-physicians will receive a certificate of participation.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1 contact hour.
CEU: The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 1 ANSI/IACET CEU for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) to receive up to 1 Category I CECH in health education. CDC provider number GA0082.
ACPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-11-071-L01-P 0387and 0387-0000-11-071-H01-P. Course Category: This activity has been designated as Knowledge-Based.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, and the presenters for this seminar do not have financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. This presentation does not involve the unlabeled use of a product or product under investigational use. There is no commercial support for this activity.
- Go to the CDC Training & Continuing Education Online System.
- Log in as a participant. If this is your first visit, you will need to register and establish a login name and password.
- Click on Search and Register.
- Under “keyword search” find the course you are interested in by entering:
- “EC1648” for calls hosted in last 30 days
- “WD1648” for calls hosted past 30 days
If you cannot participate in the live COCA Conference Call, you can still get CE credit/contact hours
- Download the PowerPoint or webinar.
- Complete the on-line evaluation within a year (and follow the instructions above.)
- CE certificates can be printed immediately upon completion of your online evaluation.
Page last updated January 20, 2012
- Content source: CDC Emergency Risk Communication Branch (ERCB), Division of Emergency Operations (DEO), Office of Public Health Preparedness and Response (OPHPR)
Get email updates
Sign up for COCA email updates.
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333
TTY: (888) 232-6348
24 Hours/Every Day